In 2015, AstraZeneca settled a lawsuit for allegedly participating in a kickback scheme. The Justice Department alleged that AstraZeneca violated the False Claims Act, and rather than facing trial, AstraZeneca quickly settled for $7.9 million. admin In 2013, AtraZeneca settled a class action lawsuit before trial when plaintiffs claimed AstraZeneca deceptively marketed Nexium as a superior acid reflux treatment, causing consumers to pay nearly 8x more instead of using the cheaper, equally effective generic version. In February 2017 the U.S. Judicial Panel on Multidistrict Litigation denied motion to combine 39 federal lawsuits against various PPI manufacturers into a single MDL.